Invention Grant
- Patent Title: Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
-
Application No.: US15052368Application Date: 2016-02-24
-
Publication No.: US10603311B2Publication Date: 2020-03-31
- Inventor: Michal Geva , Ilya Bezprozvanny , Merav Bassan , Michael Hayden
- Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
- Applicant Address: IL Herzliya US TX Austin
- Assignee: PRILENIA NEUROTHERAPEUTICS LTD.,THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: PRILENIA NEUROTHERAPEUTICS LTD.,THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: IL Herzliya US TX Austin
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: A61K31/451
- IPC: A61K31/451 ; C07D211/24 ; C07D211/52 ; C07D211/42
Abstract:
This invention provides a method of improving cognitive function in a subject comprising periodically administering to the subject an amount of pridopidine or a pharmaceutically acceptable salt thereof effective to improve a cognitive function in the subject.The invention also provides a method of treating a subject afflicted with Alzheimer's disease, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine or a pharmaceutically acceptable salt thereof effective to treat the subject.
Public/Granted literature
- US20160243098A1 USE OF PRIDOPIDINE TO IMPROVE COGNITIVE FUNCTION AND FOR TREATING ALZHEIMER'S DISEASE Public/Granted day:2016-08-25
Information query
IPC分类:
